glp-1 coverage news insurers Insurance companies scrambling to support need for drugs - Insurance Your Employer Can Cover Your
Description
They focus on lasting behavior changenot shortterm intervention
A recently published, randomized, placebo-controlled trial found a greater reduction in BMI z-score (0.22 SDs) in adolescents receiving liraglutide compared with placebo
-1,
The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for medical procedures
Glucagon-like peptide-1 (GLP-1) receptor agonists were touted as breakthrough drugsin 2023 and their popularity has soared since. More than 4 million items of tirzepatide and semaglutide were dispensed on the NHS in England in 2025/20261, while around2.5 million people each monthaccessed GLP-1s privately at the end of 2025, according to James Kingsland, chair of []
GLP-1 medications like semaglutide and tirzepatide are FDA-approved treatments that support sustainable weight loss by regulating appetite, improving insulin sensitivity, and addressing metabolic challenges.
